May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency?

No abstract available

Source: Blood Coagulation and Fibrinolysis - January 1, 2019 Category: Hematology Tags: LETTER TO THE EDITOR Source Type: research